Online citations, reference lists, and bibliographies.
← Back to Search

MR Imaging Of Triple-negative Breast Cancer

T. Uematsu
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Little is known about the MR imaging features of triple-negative breast cancer (TNBC), but TNBC has a worse prognosis because it has no effective therapeutic targets, such as estrogen receptor for endocrine therapy and human epidermal growth factor receptor 2 (HER2) for anti-HER2 therapy. MR findings of a unifocal lesion, mass lesion type, smooth mass margin, rim heterogeneous enhancement, persistent enhancement pattern, and very high signal intensity on T2-weighted images are typical features of breast MR imaging associated with TNBC. Although TNBC can mimic a benign morphology, the early MR imaging recognition of TNBC could assist in both the pretreatment planning and the prognosis, as well as adding to our understanding of the biological behavior of TNBC.
This paper references
10.1016/S0033-8389(01)00017-3
Breast imaging reporting and data system (BI-RADS).
L. Liberman (2002)
10.1148/RG.265055176
How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system.
D. Rausch (2006)
10.1016/J.EJRAD.2006.08.030
The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language?
D. Vanel (2007)
10.1093/annonc/mdp492
Triple-negative breast cancer--current status and future directions.
O. Gluz (2009)
10.3109/02841851.2010.497164
Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? a retrospective analysis stratified by mammographic BI-RADS classes
M. Benndorf (2010)
10.1148/radiol.2503081054
Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
T. Uematsu (2009)
10.1016/j.mric.2010.02.011
Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts.
M. Chatterji (2010)
10.1200/JCO.2007.13.1748
Basal-like breast cancer: a critical review.
E. Rakha (2008)
10.1016/j.ejca.2010.02.015
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
F. Sardanelli (2010)
10.1186/bcr1771
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
B. Kreike (2007)
10.2214/AJR.09.2355
Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI.
B. Dogan (2010)
10.2463/MRMS.7.195
Circumscribed mass lesions on mammography: dynamic contrast-enhanced MR imaging to differentiate malignancy and benignancy.
T. Okafuji (2008)
10.1148/RADIOL.2442051620
The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.
C. Kuhl (2007)
10.1148/RADIOL.2461062173
Mammographic, US, and MR imaging phenotypes of familial breast cancer.
S. Schrading (2008)
10.1148/RADIOL.2392050205
Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis.
A. Teifke (2006)



This paper is referenced by
Triple negative breast cancer diagnosis
R. Briedienė (2014)
10.1007/s00117-018-0409-1
Imaging and the completion of the omics paradigm in breast cancer
D. Leithner (2018)
10.1016/j.clinimag.2017.10.016
Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Giulia Angelini (2018)
10.1016/J.BREASTDIS.2015.04.018
Imaging Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysis
Wendie A. Berg (2015)
Au-delà de la mesure de SUV en imagerie TEP : propriétés et potentiel des paramètres de texture pour caractériser les tumeurs
F. Orlhac (2015)
10.1016/j.acra.2018.06.014
Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.
S. Gigli (2019)
10.1186/s13244-019-0795-6
Combining molecular and imaging metrics in cancer: radiogenomics
R. Lo Gullo (2020)
10.1371/journal.pone.0094017
Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer
M. Soussan (2014)
10.1007/s00117-020-00801-3
Multimodale, parametrische und genetische Brustbildgebung
Roberto LoGullo (2021)
10.1016/j.crad.2017.10.021
Clinical role of breast MRI now and going forward.
D. Leithner (2018)
Utility of 18F-FDG PET/CT and MRI imaging findings for predicting the clinicopathologic subtypes of triple negative breast cancer
K. Kubota (2017)
10.1155/2017/4896310
Fluorine-19 Magnetic Resonance Imaging and Positron Emission Tomography of Tumor-Associated Macrophages and Tumor Metabolism
Soo Hyun Shin (2017)
10.6001/actamedica.v18i2.1822
Radiological diagnostics of triple negative breast cancer: a review
Sigutė Stadalnykaitė (2011)
10.1093/ANNONC/MDS191
Imaging of triple-negative breast cancer.
B. Dogan (2012)
10.3892/ol.2018.9312
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification
M. Zhao (2018)
10.3390/diagnostics10121090
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
Giuliana Moffa (2020)
Semantic Scholar Logo Some data provided by SemanticScholar